Header Logo

Connection

DON LYNN GIBBONS to Adolescent

Back to Details
This is a "connection" page, showing publications DON LYNN GIBBONS has written about Adolescent.
DON LYNN GIBBONS
Connection Strength
0.041
Adolescent
  1. Phase I/II Trial of Immunotherapy With Durvalumab and Tremelimumab With Continuous or Intermittent MEK Inhibitor Selumetinib in NSCLC: Early Trial Report. Clin Lung Cancer. 2020 07; 21(4):384-388.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.